Prevalence and clinical significance of conduction disease in patients with idiopathic pulmonary arterial hypertension

J Heart Lung Transplant. 2022 Jul;41(7):861-865. doi: 10.1016/j.healun.2022.03.024. Epub 2022 Apr 7.

Abstract

Anatomical and physiological changes in the right heart as a direct consequence of the upstream pressure overload characteristic of idiopathic pulmonary hypertension (IPAH) are likely to lead to conduction disease in these patients. However, the prevalence and clinical implications of atrioventricular conduction disease in IPAH patients are not well-characterized. In this observational cohort study, we show that conduction disease is far more prevalent in a cohort of 175 IPAH patients than a group of matched comparators (37.1% vs 10.8%), and is associated with older age, male sex and more severe right heart dilatation. However, conduction disease is independently associated with worse functionality and higher mortality in this patient group. Prospective study is required to substantiate this, and whether intervention such as prophylactic pacing could restore prognosis.

Keywords: cardiac conduction disease; pacing and electrophysiology; pulmonary vascular disease; quality of life.

Publication types

  • Observational Study

MeSH terms

  • Familial Primary Pulmonary Hypertension / diagnosis
  • Familial Primary Pulmonary Hypertension / epidemiology
  • Heart
  • Humans
  • Male
  • Prevalence
  • Prognosis
  • Prospective Studies
  • Pulmonary Arterial Hypertension*